IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
172 hedge funds and large institutions have $1.04B invested in Impax Laboratories, Inc. in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
21% less call options, than puts
Call options by funds: $1.64M | Put options by funds: $2.06M
Holders
172
Holding in Top 10
1
Calls
$1.64M
Puts
$2.06M
Top Buyers
| 1 | +$114M | |
| 2 | +$21.6M | |
| 3 | +$13.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.4M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$10.3M |
Top Sellers
| 1 | -$35.5M | |
| 2 | -$32.2M | |
| 3 | -$31.7M | |
| 4 |
SIG
Senator Investment Group
New York
|
-$13.9M |
| 5 |
PC
PointState Capital
New York
|
-$12.3M |